Myriad Genetics Inc (MYGN)
18.78
+0.12
(+0.67%)
USD |
NASDAQ |
Apr 18, 10:41
Myriad Genetics Cash from Investing (TTM): 31.90M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 31.90M |
September 30, 2023 | 8.30M |
June 30, 2023 | 22.20M |
March 31, 2023 | -1.60M |
December 31, 2022 | -77.50M |
September 30, 2022 | -67.80M |
June 30, 2022 | 211.80M |
March 31, 2022 | 224.90M |
December 31, 2021 | 274.40M |
September 30, 2021 | 317.40M |
June 30, 2021 | 36.70M |
March 31, 2021 | 58.90M |
September 30, 2020 | 43.50M |
June 30, 2020 | 19.30M |
March 31, 2020 | 13.50M |
December 31, 2019 | -13.60M |
September 30, 2019 | -14.50M |
June 30, 2019 | -286.40M |
March 31, 2019 | -282.00M |
December 31, 2018 | -278.90M |
September 30, 2018 | -275.40M |
June 30, 2018 | -11.60M |
March 31, 2018 | -16.20M |
December 31, 2017 | -6.00M |
September 30, 2017 | -3.50M |
Date | Value |
---|---|
June 30, 2017 | -146.30M |
March 31, 2017 | -194.40M |
December 31, 2016 | -220.00M |
September 30, 2016 | -258.40M |
June 30, 2016 | -91.40M |
March 31, 2016 | -50.40M |
December 31, 2015 | -9.40M |
September 30, 2015 | 22.40M |
June 30, 2015 | 40.90M |
March 31, 2015 | 25.37M |
December 31, 2014 | -0.573M |
September 30, 2014 | 18.96M |
June 30, 2014 | -17.10M |
March 31, 2014 | -82.71M |
December 31, 2013 | -33.58M |
September 30, 2013 | -78.46M |
June 30, 2013 | -74.90M |
March 31, 2013 | 0.865M |
December 31, 2012 | -91.03M |
September 30, 2012 | -41.36M |
June 30, 2012 | -38.89M |
March 31, 2012 | -91.65M |
December 31, 2011 | -5.355M |
September 30, 2011 | -73.60M |
June 30, 2011 | -54.39M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-286.40M
Minimum
Jun 2019
317.40M
Maximum
Sep 2021
44.52M
Average
20.75M
Median
Cash from Investing (TTM) Benchmarks
Stryker Corp | -962.00M |
Haemonetics Corp | -327.34M |
Perspective Therapeutics Inc | 24.37M |
Electromed Inc | -1.219M |
Xtant Medical Holdings Inc | -24.78M |